Functional remediation improves bipolar disorder functioning with no effects on brain-derived neurotrophic factor levels

被引:11
|
作者
del Mar Bonnin, Caterina [1 ]
Valls, Elia [1 ]
Rosa, Adriane R. [2 ]
Reinares, Maria [1 ]
Jimenez, Esther [1 ]
Sole, Brisa [1 ]
Montejo, Laura [1 ]
Meseguer, Ana [3 ]
Pacchiarotti, Isabella [1 ]
Colom, Francesc [4 ]
Martinez-Aran, Anabel [1 ]
Tomioka, Yoko [1 ]
Vieta, Eduard [1 ]
Torrent, Carla [1 ]
机构
[1] Univ Barcelona, Barcelona Bipolar & Depress Disorders Program, Hosp Clin Barcelona, Inst Neurosci,IDIBAPS,CIBERSAM, Catalonia, Spain
[2] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[3] Univ Barcelona, Neurosci Inst, Hosp Clin Barcelona, Barcelona Clin Schizophrenia Unit, Catalonia, Spain
[4] Hosp del Mar, IMIM Inst Hosp Mar Invest Med, Mental Hlth Grp, CIBERSAM, Barcelona, Catalonia, Spain
关键词
Bipolar disorder; Functional remediation; Psychoeducation; BDNF; Functioning; VAL66MET POLYMORPHISM; RATING-SCALE; SERUM-LEVELS; BDNF; SCHIZOPHRENIA; RELIABILITY; DEPRESSION; KETAMINE; VALIDITY; BURDEN;
D O I
10.1016/j.euroneuro.2019.04.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The main aim of this study is to evaluate the impact of functional remediation (FR) in serum brain derived neurotrophic factor (BDNF) levels in euthymic adult patients with Bipolar Disorder (BD). A total of 128 participants were recruited at the Hospital Clinic of Barcelona. They were assessed at baseline and at the end of follow-up by the means of Hamilton Depression Scale (HAM-D), Young Mania Rating Scale (YMRS) and Functioning Assessment Short Test (FAST), as well as a clinical structured interview to collect clinical and demographic variables of interest. Blood samples were also collected to assess BDNF levels. After baseline assessment, patients received FR, Psychoeducation or treatment as usual (TAU). One hundred and two out of 126 participants finished the study distributed as follows: FR group (n = 39); Psychoeducation group (n = 47) and TAU group (n = 16). Longitudinal repeated-measures analyses addressing the treatment effect on BDNF levels showed non-significant differences between the three groups (Pillai's trace = 0.06; F-(2,F-97) = 0.28; p = 0.75), suggesting no interaction between treatment allocation and time on BDNF levels. The results of this study suggest that FR has no effect on peripheral BDNF levels in euthymic patients with BD, despite the improvement in psychosocial functioning. (C) 2019 Elsevier B.V. and ECNP. All rights reserved.
引用
收藏
页码:701 / 710
页数:10
相关论文
共 50 条
  • [41] Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study
    Karthikeyan, Sudhir
    Dimick, Mikaela K.
    Fiksenbaum, Lisa
    Jeong, Hyunjin
    Birmaher, Boris
    Kennedy, James L.
    Lanctot, Krista
    Levitt, Anthony J.
    Miller, Gregory E.
    Schaffer, Ayal
    Young, L. Trevor
    Youngstrom, Eric A.
    Andreazza, Ana C.
    Goldstein, Benjamin I.
    BRAIN BEHAVIOR AND IMMUNITY, 2022, 100 : 278 - 286
  • [42] Brain-derived neurotrophic factor in bipolar disorder: beyond trait and state: comment on 'Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders'
    Kapczinski, Flavio
    Dias, Vasco Videira
    Frey, Benicio N.
    Anna, Marcia Kauer-Sant'
    BIPOLAR DISORDERS, 2009, 11 (02) : 221 - 222
  • [43] Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes
    Cunha, Angelo B. M.
    Frey, Benicio N.
    Andreazza, Ana C.
    Goi, Julia D.
    Rosa, Adriane R.
    Goncalves, Carlos A.
    Santin, Aida
    Kapczinski, Flavio
    NEUROSCIENCE LETTERS, 2006, 398 (03) : 215 - 219
  • [44] Serum levels of brain-derived neurotrophic factor in Sydenham's chorea
    Teixeira, Antonio Lucio
    Bretas, Thales Lage
    Kummer, Arthur
    Melo, Livia Cunha
    Baraldi, Amanda
    Harsanyi, Estefania
    Cardoso, Francisco
    da Silva Camargos, Elizabeth Ribeiro
    NEUROLOGICAL SCIENCES, 2010, 31 (03) : 399 - 401
  • [45] Can Brain-Derived Neurotrophic Factor Be Considered a Biomarker for Bipolar Disorder? An Analysis of the Current Evidence
    De Felice, Gianmarco
    Luciano, Mario
    Boiano, Alessia
    Colangelo, Giulia
    Catapano, Pierluigi
    Della Rocca, Bianca
    Lapadula, Maria Vita
    Piegari, Elena
    Toni, Claudia
    Fiorillo, Andrea
    BRAIN SCIENCES, 2023, 13 (08)
  • [46] Decreased peripheral brain-derived neurotrophic factor levels are not specific for bipolar disorder, major depressive disorder or schizophrenia: a meta-analysis
    Fernandes, B. S.
    Berk, M.
    Goncalves, C.
    BIPOLAR DISORDERS, 2013, 15 : 40 - 40
  • [47] Serum brain-derived neurotrophic factor levels in conversion disorder: Comparative study with depression
    Deveci, Artuner
    Aydemir, Omer
    Taskin, Oryal
    Taneli, Fatma
    Esen-Danaci, Aysen
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2007, 61 (05) : 571 - 573
  • [48] Serum level of brain derived neurotrophic factor (BDNF) among patients with bipolar disorder
    Rabie, Menan A.
    Mohsen, Manal
    Ibrahim, Mona
    Mahmoud, Rania El-Sawy
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 162 : 67 - 72
  • [49] Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression
    Nomoto, Hiroshi
    Baba, Hajime
    Satomura, Emi
    Maeshima, Hitoshi
    Takebayashi, Naoko
    Namekawa, Yuki
    Suzuki, Toshihito
    Arai, Heii
    BMC PSYCHIATRY, 2015, 15
  • [50] Brain-derived neurotrophic factor levels and cognitive dysfunction in euthymic bipolar type I patients
    Videira Dias, V.
    Brissos, S.
    Frey, B. N.
    Andreazza, A. C.
    Kapczinski, F.
    BIPOLAR DISORDERS, 2009, 11 : 88 - 88